+8618116577817
sinobiopharm@gmail.com
Home
Products
News
About
Contact
NEWS
Company News
Industry News
2025-12-08
Shengnuo Bio Enters Strategic Cooperation with Brazilian "Belt and Road" Institution to Forge New Pathway for Peptide APIs in South America
Shengnuo Bio has signed a strategic agreement with a Brazilian "Belt and Road" institution to cooperate on the supply of peptide APIs, technology exchange, and market channel development, with a focus on promoting GLP-1 class APIs such as Semaglutide and Tirzepatide in the Brazilian market. This collaboration marks the extension of the company's overseas presence into the core South American market and provides a practical pathway for China-Brazil biomedical cooperation under the "Belt and Road" framework.
2025-11-12
Live from the Event | Shengnuo Biopharm Makes a Splash at the 93rd API China, Leading the Future in Peptides
The 93rd API China kicked off successfully in Chongqing on November 12, with Shengnuo Biopharm (Booth N5 Hall 5L25) getting off to a strong start on the first day. The exhibition floor was buzzing with professional exchanges, as the company's demonstration of its integrated, end-to-end capabilities in peptide APIs and CDMO services attracted numerous industry professionals for in-depth discussions and garnered widespread recognition. The exhibition is still ongoing, and we sincerely invite colleagues from across the industry to visit our booth to continue the dialogue and explore collaborative opportunities.
2025-11-11
Chengdu Shengnuo Biopharm Co., Ltd. Cordially Invites You to the 93rd API China Exhibition – Join the Dialogue on Innovation and Development in the Peptide Field
Chengdu Shengnuo Biopharm sincerely invites you to attend the 93rd China International Pharmaceutical Raw Materials, Intermediates, Packaging, and Equipment Trade Fair (API China 2025). Join us from November 12–14, 2025, at Booth No. 5L25, Hall N5, Chongqing International Expo Center, as we explore cutting-edge technologies and collaboration opportunities in the peptide sector.
2025-10-31
Chengdu Shengnuo Biopharm Co., Ltd.—Semaglutide, Tirzepatide and Other API Industrialization Base Project Commences Construction Grandly
October 30, 2025 – Chengdu Shengnuo Biopharm Co., Ltd. held the project commencement ceremony in Dayi Economic Development Zone, marking the official start of construction for the Semaglutide, Tirzepatide, and other peptide Active Pharmaceutical Ingredient (API) industrialization base project.
2025-09-24
On-Site Report! Our Team Has Arrived at PHARMEDI VIETNAM 2025 – See You at Booth B-6
2025-09-19
Chengdu Shengnuo Biopharmaceutical Co., Ltd. to Participate in PHARMEDI VIETNAM 2025
